1. Home
  2. SONM vs NKGN Comparison

SONM vs NKGN Comparison

Compare SONM & NKGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SONM
  • NKGN
  • Stock Information
  • Founded
  • SONM 1999
  • NKGN 2017
  • Country
  • SONM United States
  • NKGN United States
  • Employees
  • SONM N/A
  • NKGN N/A
  • Industry
  • SONM Telecommunications Equipment
  • NKGN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SONM Telecommunications
  • NKGN Health Care
  • Exchange
  • SONM Nasdaq
  • NKGN Nasdaq
  • Market Cap
  • SONM 15.0M
  • NKGN 13.5M
  • IPO Year
  • SONM 2019
  • NKGN N/A
  • Fundamental
  • Price
  • SONM $2.83
  • NKGN $0.41
  • Analyst Decision
  • SONM
  • NKGN
  • Analyst Count
  • SONM 0
  • NKGN 0
  • Target Price
  • SONM N/A
  • NKGN N/A
  • AVG Volume (30 Days)
  • SONM 19.4K
  • NKGN 388.3K
  • Earning Date
  • SONM 11-12-2024
  • NKGN 11-12-2024
  • Dividend Yield
  • SONM N/A
  • NKGN N/A
  • EPS Growth
  • SONM N/A
  • NKGN N/A
  • EPS
  • SONM N/A
  • NKGN N/A
  • Revenue
  • SONM $69,288,000.00
  • NKGN N/A
  • Revenue This Year
  • SONM N/A
  • NKGN N/A
  • Revenue Next Year
  • SONM $107.78
  • NKGN N/A
  • P/E Ratio
  • SONM N/A
  • NKGN N/A
  • Revenue Growth
  • SONM N/A
  • NKGN N/A
  • 52 Week Low
  • SONM $2.32
  • NKGN $0.36
  • 52 Week High
  • SONM $10.70
  • NKGN $5.10
  • Technical
  • Relative Strength Index (RSI)
  • SONM 50.12
  • NKGN 32.54
  • Support Level
  • SONM $2.67
  • NKGN $0.36
  • Resistance Level
  • SONM $3.11
  • NKGN $0.40
  • Average True Range (ATR)
  • SONM 0.27
  • NKGN 0.06
  • MACD
  • SONM 0.04
  • NKGN 0.01
  • Stochastic Oscillator
  • SONM 27.17
  • NKGN 13.79

About SONM Sonim Technologies Inc.

Sonim Technologies Inc is a provider of ultra-rugged mobile devices, including phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. The company sells mobile phones, accessories, and solutions to AT&T, T-Mobile, and Verizon in the United States, and to Bell, Rogers, and Telus Mobility in Canada. The products include rugged mobile phones that can attach to both public and private wireless networks, industrial-grade accessories that meet the requirements of specific applications and software applications, and cloud-based tools that provide management and deployment services to customers. The company generates revenue from discounts, price protection, and customer incentives.

About NKGN NKGen Biotech Inc.

NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.

Share on Social Networks: